We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Cold Plasma Cloud Makes Wounds Heal Faster

By HospiMedica International staff writers
Posted on 24 Jun 2015
An innovative device uses plasma gas for local treatment of microbial contaminated and infected skin and wounds.

The PlasmaDerm device creates a cool, tissue-compatible plasma cloud aimed at the wound site. More...
The treatment involves placing the electrode of the device close to the skin, with the skin itself acting as the second electrode. A high frequency, high voltage alternating current is then applied across the gap, and the resulting electric fields convert the ambient air in the area between the electrode and the skin into non-thermal plasma, visible as a faint purple mist at the device’s tip. The device is gently moved in small circles to increase treatment area.

The cold plasma acts through the combination of a therapeutic electrical field, low irradiation in the beneficial ultraviolet (UV) UV-A and UV-B wave length range, and the activated gas particles from ambient air. The result is a deep stimulation of the treated skin and wound surfaces, inducing sustainably increased blood microcirculation in the area which resulting in an increased supply of oxygen and nutrients. To achieve optimal results, the therapy should be repeated twice to three times weekly over a period of two to three weeks.

Developed by the researchers at the Fraunhofer Institute for Surface Engineering and Thin Films (IST; Braunschweig, Germany), in collaboration with Cinogy (Duderstadt, Germany), the PlasmaDerm device has been found to be effective even against multi-resistant problem germs, such as Methicillin-resistant Staphylococcus aureus (MRSA).

“Non-thermal plasma actually combines the mechanisms of different therapies. UV, ozone, and electrotherapy are already available, but plasma achieves a better effect in a shorter period of time,” said Prof. Steffen Emmert, MD, of University Medical Center Göttingen (Germany). “Plasma reduces the bacteria count on the skin’s surface, while the electric field simultaneously boosts the skin’s microcirculation by allowing more oxygen to be delivered. These are both decisive factors in improving wound healing.”

Related Links:

Fraunhofer Institute for Surface Engineering and Thin Films
Cinogy
University Medical Center Göttingen



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.